aTyr Pharma | LIFE - Заемный капитал





Заемный капитал Изменить Дата
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Ardelyx USD 203.52M 683K 2026-03
aTyr Pharma USD 1.72M 10.79M 2026-03
Biogen USD 6.29B 1.7M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Cipla INR 3.82B 840.2M 2026-03
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Curis USD 29.43M 10.69M 2024-06
GlaxoSmithKline GBP 14.01B 696M 2026-03
Grifols EUR 9.95B 722.93M 2025-12
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Novartis USD 37.45B 7.86B 2026-03
Roche Holding CHF 27.43B 966M 2025-12
United Therapeutics USD 100M 100M 2024-06
Xoma USD 94.38M 7.82M 2025-09